Matt Miksic
Stock Analyst at Barclays
(3.79)
# 1,996
Out of 5,090 analysts
827
Total ratings
53.4%
Success rate
3.1%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiated Coverage: Buy | $143 → $120 | $103.10 | +16.39% | 51 | Oct 7, 2026 | |
| AVR Anteris Technologies Global | Initiated Coverage: Hold | $18 → $10 | $6.00 | +66.67% | 7 | Oct 7, 2026 | |
| BAX Baxter International | Initiated Coverage: Sell | $27 → $20 | $24.92 | -19.74% | 42 | Oct 7, 2026 | |
| BDX Becton, Dickinson and Company | Initiated Coverage: Sell | $204 → $165 | $195.03 | -15.40% | 24 | Oct 7, 2026 | |
| BLCO Bausch + Lomb | Initiated Coverage: Buy | $20 → $24 | $17.62 | +36.21% | 19 | Oct 7, 2026 | |
| BSX Boston Scientific | Initiated Coverage: Hold | $89 → $48 | $45.06 | +6.52% | 51 | Oct 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Buy | $64 → $115 | $78.56 | +46.38% | 23 | Oct 7, 2026 | |
| EW Edwards Lifesciences | Initiated Coverage: Buy | $110 | $90.82 | +21.12% | 59 | Oct 7, 2026 | |
| GEHC GE HealthCare Technologies | Initiated Coverage: Buy | $78 → $85 | $71.11 | +19.53% | 8 | Oct 7, 2026 | |
| HUMA Humacyte | Initiated Coverage: Hold | $1.5 → $0.5 | $0.4463 | +12.03% | 5 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $651 → $485 | $445.88 | +8.77% | 20 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $76 → $105 | $80.38 | +30.63% | 22 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $198 → $150 | $149.83 | +0.11% | 21 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $31 → $10 | $8.33 | +20.05% | 8 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $394 → $375 | $301.42 | +24.41% | 49 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 → $18 | $19.22 | -6.35% | 20 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $94 → $100 | $96.06 | +4.10% | 41 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $103 → $60 | $59.88 | +0.20% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $120 → $95 | $93.95 | +1.12% | 69 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $26 → $22 | $18.93 | +16.22% | 2 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $255 | $268.73 | -5.11% | 93 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $13 | $5.78 | +124.91% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $123 | $80.90 | +52.04% | 49 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $19 | $13.58 | +39.91% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $24 | $10.87 | +120.79% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 74.49 → CHF 64.56 | CHF 57.58 | +12.12% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.9024 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $722 → $418 | $151.95 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $0.015 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $28 | $18.49 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $67 | $9.35 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $84.25 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 → $87 | $11.99 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $23.58 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $3.90 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $1.70 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 | $30.10 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $8.18 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $47.20 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $9.71 | n/a | 3 | Mar 14, 2013 |
Abbott Laboratories
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $143 → $120
Current: $103.10
Upside: +16.39%
Anteris Technologies Global
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $18 → $10
Current: $6.00
Upside: +66.67%
Baxter International
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $27 → $20
Current: $24.92
Upside: -19.74%
Becton, Dickinson and Company
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $204 → $165
Current: $195.03
Upside: -15.40%
Bausch + Lomb
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $20 → $24
Current: $17.62
Upside: +36.21%
Boston Scientific
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $89 → $48
Current: $45.06
Upside: +6.52%
DexCom
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $64 → $115
Current: $78.56
Upside: +46.38%
Edwards Lifesciences
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $110
Current: $90.82
Upside: +21.12%
GE HealthCare Technologies
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $78 → $85
Current: $71.11
Upside: +19.53%
Humacyte
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $1.5 → $0.5
Current: $0.4463
Upside: +12.03%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $651 → $485
Current: $445.88
Upside: +8.77%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $76 → $105
Current: $80.38
Upside: +30.63%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $198 → $150
Current: $149.83
Upside: +0.11%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $31 → $10
Current: $8.33
Upside: +20.05%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $394 → $375
Current: $301.42
Upside: +24.41%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $55 → $18
Current: $19.22
Upside: -6.35%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $94 → $100
Current: $96.06
Upside: +4.10%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $103 → $60
Current: $59.88
Upside: +0.20%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $120 → $95
Current: $93.95
Upside: +1.12%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $26 → $22
Current: $18.93
Upside: +16.22%
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $268.73
Upside: -5.11%
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $5.78
Upside: +124.91%
May 11, 2026
Reiterated: Buy
Price Target: $123
Current: $80.90
Upside: +52.04%
May 7, 2026
Reiterated: Buy
Price Target: $21 → $19
Current: $13.58
Upside: +39.91%
May 6, 2026
Reiterated: Buy
Price Target: $27 → $24
Current: $10.87
Upside: +120.79%
May 6, 2026
Reiterated: Hold
Price Target: CHF 74.49 → CHF 64.56
Current: CHF 57.58
Upside: +12.12%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $0.9024
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $722 → $418
Current: $151.95
Upside: n/a
Mar 4, 2022
Reiterated: Buy
Price Target: $16 → $13
Current: $0.015
Upside: n/a
Mar 2, 2022
Reiterated: Buy
Price Target: $31 → $28
Current: $18.49
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $74 → $67
Current: $9.35
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $100
Current: $84.25
Upside: n/a
Nov 3, 2021
Reiterated: Buy
Price Target: $79 → $87
Current: $11.99
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $23.58
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $3.90
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $1.70
Upside: n/a
Nov 3, 2014
Reiterated: Hold
Price Target: $37
Current: $30.10
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $8.18
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $47.20
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $9.71
Upside: n/a